Table 1.
Demographic information, pathological stage and diagnosis, lesions seen by white light, and fluorescence imaging
| Case no. | Sex/age (y) | Pathological stage | Pathological diagnosis | Grade | Lesion number | White light diagnosis | Fluorescence imaging |
| 1 | M/63 | pT3aN1 | Infiltrating high-grade urothelial carcinoma, CIS and necrosis | HGI | 1 | + | + |
| 2 | M/61 | pT0N0 | Diverticulum with urothelial atypia and treatment effects | + | + | ||
| 3 | F/84 | ypT3bN0 | Invasive high-grade urothelial carcinoma | HGI | 2 | + | + |
| Invasive high-grade urothelial carcinoma and necrosis | HGI | 3 | + | + | |||
| 4 | M/51 | pT2aN1 | Residual infiltrative high-grade urothelial carcinoma micropapillary features, dysplasia and necrosis | HGI | 4 | + | + |
| 5 | M/69 | pTaN0 | Noninvasive high-grade papillary carcinoma | HGN | 5 | + | + |
| 6 | M/65 | pT1N0 | Residual invasive high-grade urothelial carcinoma, CIS and necrosis | HGI | 6 | + | + |
| CIS | CIS | 7 | + | + | |||
| CIS | CIS | 8 | + | + | |||
| 7 | M/61 | pT1N0 | Focally invasive high-grade urothelial carcinoma, necrosis | HGI | 9 | + | + |
| 8 | M/79 | pT1N0 | Dysplasia | DIS | 10 | − | + |
| Treatment effect and CCCG | − | + | |||||
| 9 | M/74 | pT0N0 | CCCG | − | + | ||
| 10 | F/82 | pT1N0 | Noninvasive high-grade urothelial carcinoma | HGN | 11 | + | + |
| Invasive high-grade urothelial carcinoma | HGI | 12 | + | − | |||
| CIS | CIS | 13 | − | + | |||
| CIS and CCCG | CIS | 14 | − | + | |||
| 11 | M/68 | pTisN0 | CIS and CCCG | CIS | 15 | + | + |
| CIS | CIS | 16 | − | + | |||
| 12 | M/71 | pTisN0 | Noninvasive high-grade urothelial carcinoma | HGN | 17 | + | + |
| Noninvasive high-grade urothelial carcinoma | HGN | 18 | + | + | |||
| CIS | CIS | 19 | − | + | |||
| CIS | CIS | 20 | − | + | |||
| 13* | M/66 | pT3N1 | Invasive high-grade urothelial carcinoma | + | ICG-Cys | ||
| Ulceration, necrosis, CCCG | + | ||||||
| 14 | M/66 | pT1N0 | Noninvasive high-grade urothelial carcinoma | HGN | 21 | + | + |
| 15 | M/57 | pT1N0 | Invasive high-grade urothelial carcinoma | HGI | 22 | + | + |
| 16 | F/77 | pTisN0 | CIS with early invasion | CIS | 23 | + | + |
| CIS with early invasion | CIS | 24 | − | + | |||
| 17† | M/57 | pT1bN0 | Invasive high-grade urothelial carcinoma | HGI | 25 | + | + |
| CIS with early invasion | CIS | 26 | + | + | |||
| Necrosis and treatment effect | + | + | |||||
| 18† | M/72 | pT3aN0 | Invasive high-grade urothelial carcinoma, CIS | HGI | 27 | + | + |
| Necrosis and treatment effect in diverticulum | + | − | |||||
| 19 | M/64 | pT2aN0 | Invasive high-grade urothelial carcinoma, CIS, Necrosis and treatment effect | + | ICG-Cys | ||
| 20 | M/63 | ypT0N0 | CCCG and reactive changes in scar | + | ICG-Cys | ||
| 21 | M/74 | pT3aN0 | Invasive high-grade urothelial carcinoma in scar | HGI | 28 | + | + |
| Necrosis | + | + | |||||
| 22† | M/66 | ypT3aN0 | Invasive high-grade urothelial carcinoma with neuroendocrine features | HGI | 29 | + | + |
+, Lesion was detected by white light or fluorescence imaging; −, lesion was not detected by white light or fluorescence imaging.
Forty micromolar of 80 mL construct was used for instillation.
Four micromolar of 80 mL construct was used for instillation.